{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:08:04Z","timestamp":1768316884540,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.contraception.2014.05.014","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T20:00:52Z","timestamp":1401739252000},"page":"357-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions"],"prefix":"10.1016","volume":"90","author":[{"given":"Heidi E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2014.05.014_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(13)70155-5","article-title":"Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence","volume":"13","author":"Polis","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.contraception.2014.05.014_bb0010","series-title":"Hormonal contraception and the risk of HIV acquisition: an individual participant meta-analysis","author":"Morrison","year":"2013"},{"key":"10.1016\/j.contraception.2014.05.014_bb0015","series-title":"Conference on Retroviruses and Opportunistic Infections (CROI) 2014. Boston, MA","article-title":"Injectable contraception and HIV acquisition in the VOICE study (MTN-003)","author":"Noguchi","year":"2014"},{"key":"10.1016\/j.contraception.2014.05.014_bb0020","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/QAD.0b013e32833a2537","article-title":"Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling","volume":"24","author":"Morrison","year":"2010","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2014.05.014_bb0025","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/QAD.0000000000000036","article-title":"Participants of the HCHIVOAM. Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches","volume":"27","author":"Polis","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2014.05.014_bb0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/aje\/kwp219","article-title":"Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe","volume":"170","author":"Minnis","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2014.05.014_bb0035","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/QAD.0000000000000037","article-title":"Hormonal contraception and HIV: the methods have confused the message","volume":"27","author":"Schwartz","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2014.05.014_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e32834fa13d","article-title":"Hormonal contraception and the risk of HIV acquisition among women in South Africa","volume":"26","author":"Morrison","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2014.05.014_bb0045","series-title":"A (potential) randomized clinical trial to assess the relative benefits and risks, including HIV acquisition, of different highly-effective contraceptiev methods","author":"Baeten","year":"2013"},{"key":"10.1016\/j.contraception.2014.05.014_bb0050","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nm1096-1084","article-title":"Progesterone implants enhance SIV vaginal transmission and early virus load","volume":"2","author":"Marx","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.contraception.2014.05.014_bb0055","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/424600","article-title":"Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239","volume":"190","author":"Abel","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.contraception.2014.05.014_bb0060","doi-asserted-by":"crossref","first-page":"e50632","DOI":"10.1371\/journal.pone.0050632","article-title":"Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen","volume":"7","author":"Radzio","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2014.05.014_bb0065","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/JVI.77.8.4558-4565.2003","article-title":"Progesterone increases susceptibility and decreases immune responses to genital herpes infection","volume":"77","author":"Kaushic","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.contraception.2014.05.014_bb0070","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/IAI.01189-12","article-title":"The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis","volume":"81","author":"Kleynhans","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.contraception.2014.05.014_bb0075","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1210\/en.2012-1850","article-title":"Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms","volume":"154","author":"Huijbregts","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2014.05.014_bb0080","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/en.2013-1066","article-title":"Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate","volume":"154","author":"Hapgood","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2014.05.014_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2014.05.014_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1189\/jlb.1012491","article-title":"The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses","volume":"93","author":"Hughes","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.contraception.2014.05.014_bb0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mce.2013.09.022","article-title":"The immune privilege of testis and gravid uterus: same difference?","volume":"382","author":"Arck","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2014.05.014_bb0100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical A","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2014.05.014_bb0105","unstructured":"U.S. Centers for Disease Control and Prevention (CDC). Contraception: How effective are birth control methods? In: U.S. Centers for Disease Control and Prevention (CDC). http:\/\/www.cdc.gov\/reproductivehealth\/UnintendedPregnancy\/Contraception.htm [Last updated in August 2013, and accessed on May 1, 2014]."},{"key":"10.1016\/j.contraception.2014.05.014_bb0110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.contraception.2012.03.008","article-title":"Hormonal contraception and HIV acquisition risk: implications for individual users and public policies","volume":"86","author":"Jain","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.05.014_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":"Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.contraception.2014.05.014_bb0120","unstructured":"World Health Organization. Regional estimates for 2000-2011: cause-specific mortality. In. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates_regional\/en\/ [Accessed on May 1, 2014]."},{"key":"10.1016\/j.contraception.2014.05.014_bb0125","series-title":"Family planning worldwide 2013 Data Sheet","author":"Population Reference Bureau","year":"2013"},{"key":"10.1016\/j.contraception.2014.05.014_bb0130","series-title":"South Africa Demographic and Health Survey 2003","author":"Department of Health MRC","year":"2007"},{"key":"10.1016\/j.contraception.2014.05.014_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.9745\/GHSP-D-13-00010","article-title":"Use of modern contraception increases when more methods become available: analysis of evidence from 1982-2009","volume":"1","author":"Ross","year":"2013","journal-title":"Glob Health Sci Pract"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414002959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414002959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T13:58:55Z","timestamp":1538575135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414002959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0010782414002959"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.05.014","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}